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Reactome<p>Reactome, an online curated resource for human pathway data, can be used to infer equivalent reactions in non-human species and as a tool to aid in the i terpretation of microarrays and other high-throughput data sets.</p>
Abstract
Reactome http://www.reactome.org, an online curated resource for human pathway data, provides
infrastructure for computation across the biologic reaction network. We use Reactome to infer
equivalent reactions in multiple nonhuman species, and present data on the reliability of these
inferred reactions for the distantly related eukaryote Saccharomyces cerevisiae. Finally, we describe
the use of Reactome both as a learning resource and as a computational tool to aid in the
interpretation of microarrays and similar large-scale datasets.
Rationale
When the human genome program was first envisioned, it
was anticipated that having a catalog of all of the genes in the
human body would vastly enhance our knowledge of how
these components work together. Although the availability of
the genome sequence has indeed given us a powerful tool to
improve our understanding of biology, it has revealed the dif-
ficulty of deriving the principles of biology from its individual
parts. An apt analogy is an attempt to deduce the principles of
powered flight, let alone the working details of a modern air-
craft, from the components of an Airbus 380 laid out on a
hanger floor.
Although the comprehensive genome sequence has only
recently been revealed, biologists have been characterizing
the roles played by specific proteins in specific processes for
nearly a century. Although this information is not compre-
hensive for any organism, it spans a considerable breadth of
knowledge and is sometimes exquisitely detailed. Examples
range from the oxidative metabolism of sugar molecules [1],
through the molecular control of the cell cycle [2], to the
atomic details of selective ion transport [3]. This information
is stored as primary literature, review articles, and human
memories. It is transmitted between researchers by printed,
digital, and oral routes, but it remains largely inaccessible to
computational investigation. Much biomedic literature is
now available in online form, but attempts to use it for com-
putational analysis must confront the unsolved problems of
natural language processing. Hence, if we wish to reason with
this information, then we must do so in the traditional way -
by collating all information possibly related to the subjects of
interest, reading it, and memorizing the relevant parts. In the
postgenomic world, however, in which information has been
gathered on tens of thousands of genes, proteins, and other
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becomes increasingly difficult to put into practice.
Inability to manipulate this knowledge computationally is
most keenly felt in the analysis of high-throughput functional
data, where the lack of computationally accessible knowledge
interferes with our ability to check the high-throughput data
for consistency with what is already known. For example,
microarray profiling of insulin-sensitive versus insulin-resist-
ant tissues typically detects expression pattern changes in
hundreds of genes [4-6]. Current electronic resources do not
allow the list of differentially expressed genes to be automat-
ically cross-checked against well described pathways.
Recent efforts [7,8] have established databases of published
kinetic models of biologic processes ranging in complexity
from glycolysis to regulation of the cell cycle. These databases
allow researchers to browse and visualize pathway models
and, in some cases, to run simulations for comparison with
experimental data. Of necessity, these databases are limited
in scope to a few very well characterized pathways; they are
deep but narrow collections. On the other end of the spec-
trum, interaction databases such as Biomolecular Interaction
Network Database (BIND) [9] record the results of high-
throughput molecular interaction studies as well as limited
literature-based curation of genetic and physical interactions.
These databases are broad but shallow; individual interac-
tions have little additional information, and hence are not
easily associated with the larger biologic processes in which
they participate.
In this paper we present the Reactome knowledge base of bio-
logic processes. Like kinetic model databases, Reactome
obtains information from expert bench biologists, and like
interaction databases, Reactome strives for comprehensive-
ness. However, Reactome seeks to provide integrated, quali-
tative views of entire human biologic processes in a
computationally accessible form. Here, we describe the
design of Reactome and the operating procedures used to col-
lect, curate, and verify the quality of the contents of the data-
base, and discuss new biologic insights emerging from this
process.
The Reactome data model
At the cellular level, life is a network of molecular interac-
tions. Molecules are synthesized and degraded, transported
from one location to another, form complexes with other mol-
ecules, and undergo temporary and permanent modifica-
tions. However, all of this apparent complexity can be
reduced to a simple common representation; each step is an
event that transforms input physical entities into output
entities.
Much of the power and expressivity of any pathway database
lies in the data model used to represent these molecules and
their interactions. Reactome uses a frame-based knowledge
representation consisting of classes, or 'frames', that describe
various concepts such as reaction, pathway, and physical
entity. Pieces of biologic knowledge are captured as instances
of those classes. Classes have attributes, or 'slots', which hold
pieces of information about the instances. For example, each
reaction is represented as an instance of the class 'reaction',
whose input and output slots are filled with the reactants
(input) and products (output) of the given reaction.
The Reactome data model extends the concept of a biochem-
ical reaction to include such things as the association of two
proteins to form a complex, or the transport of an ubiquiti-
nated protein into the proteasome. Reactions are chained
together by shared physical entities; an output of one reaction
may be an input for another reaction and serve as the catalyst
for yet another reaction.
It is convenient, if arbitrary, to give such a set of interlinked
reactions a name, thereby organizing them into a goal-
directed 'pathway'. In Reactome, the reaction in which fruc-
tose-6-phosphate is formed from glucose-6-phosphate is fol-
lowed by a reaction in which fructose-6-phosphate and ATP
are transformed into fructose-2,6-bisphosphate and ADP,
and another in which - in response to the positive regulatory
effect of fructose-2,6-bisphosphate - fructose-6-phosphate
and ATP are transformed into fructose-1,6-bisphosphate and
ADP. Together, these and subsequent reactions form the 'gly-
colysis' pathway. Pathways can be part of larger pathways.
Reactome represents glycolysis and gluconeogenesis (glucose
synthesis) as parts of 'glucose metabolism', which in turn is a
part of a larger pathway named 'metabolism of small mole-
cules'. Reactome pathways are cross-referenced to the Gene
Ontology (GO) biologic process ontology [10,11].
Reactions that are driven by an enzyme are described as
requiring a catalyst activity, modeled in Reactome by linking
the macromolecule that provides the activity to the GO molec-
ular function term [10,11] that describes the activity. In addi-
tion, the Reactome data model allows reactions to be
modulated by positive and negative regulatory factors. When
a precise regulatory mechanism ('positive allosteric regula-
tion', 'noncompetitive inhibition') is known, this information
is captured.
Reactome reactions act upon 'physical entities'. Entities
include proteins, nucleic acids, small molecules, and even
subatomic particles such as photons. A physical entity can be
a single molecule, such as a polypeptide chain, or an ensemble
of components, such as a macromolecular complex.
Part of the challenge of describing biologic processes in com-
putable form is the complexity of the many transformations
in molecules that occur during the course of a pathway. Mol-
ecules are modified, moved from place to place, or cleaved, or
they may take on different three-dimensional conformations.Genome Biology 2007, 8:R39
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nMany of these modifications are critical to the process under
consideration; for example, phosphorylation of a protein at a
particular amino acid residue may convert it from an inactive
form to an active form. The Reactome data model handles
these issues by treating each form of a molecule as a separate
physical entity. Under this scheme the unphosphorylated and
phosphorylated versions of a protein become separate physi-
cal entities, and if the protein can be phosphorylated at differ-
ent residues then each distinct phosphorylation pattern is
treated separately. The corresponding phosphorylation proc-
ess is annotated as a reaction whose input is the unphospho-
rylated physical entity and whose output is the
phosphorylated version.
Because the functions of biologic molecules critically depend
on their subcellular locations, chemically identical entities
located in different compartments are represented as distinct
physical entities. For example, extracellular D-glucose and
cytosolic D-glucose are distinct Reactome entities. This
allows us to treat transport events as ordinary reactions; glu-
cose transport is a reaction that takes extracellular D-glucose
as its input, and produces cytosolic D-glucose as its output. To
annotate the subcellular locations of molecules, we use a sub-
set of the GO cellular component ontology [10,11] that has
been pruned to remove compartments that overlap with oth-
ers, such as 'intracellular'.
Reactome also treats molecules that have distinct biologically
significant conformational states as separate physical enti-
ties. For example, a key event in photoreception in the retina
is the photon-triggered isomerization of the rhodopsin 11-cis
form to the all-trans form. In Reactome, each functionally
significant rhodopsin isomer can be treated separately.
Physical entities that represent the same chemical in different
compartments, configurations, or modifications states share
much of the same information, and it would be inefficient and
error prone to replicate that information for each entity. It is
also desirable to identify all physical entities that share the
same basic chemical structure or sequence. Reactome han-
dles this using the concept of a 'reference entity', which cap-
tures the invariant features of a molecule such as its name,
reference chemical structure, amino acid or nucleotide
sequence (when relevant), and accession numbers in refer-
ence databases. The data model allows each physical entity to
refer to its reference entity, and vice versa. For the common
case of a protein that has undergone post-translational cova-
lent modification, the Reactome data model records the loca-
tion and type of the modification using the 'modified residue'
class.
Most biologic reactions involve not simple molecules, but
large macromolecular complexes, and Reactome treats each
complex as a named physical entity. This allows us to describe
molecular assembly operations, such as the recruitment of
double-strand break repair complex components to the site of
DNA damage, as a series of reactions in which the inputs and
outputs are intermediates in the formation of the DNA repair
complex. In the data model, complexes refer to all of the com-
ponents that they contain, so that it is possible to fetch all
complexes that involve a particular component or to dissect a
complex to find the individual molecules that comprise it. In
the data model, a physical entity comprised of a single mole-
cule is known as a 'simple entity', whereas entities comprising
two or more simple entities belong to the 'complex' class.
Like simple entities, complexes that have catalytic activity are
cross-referenced to the GO molecular function ontology.
When appropriate, we record which component or molecular
domain of the complex has the active site for the activity; this
aids in the transfer of knowledge to the GO database, which
associates molecular function terms with protein monomers
and cannot currently accept information about entire
complexes.
There are many cases in which it is convenient to group phys-
ical entities together into sets on the basis of common proper-
ties. For example, the SLC28A2 plasma membrane
nucleoside transporter operates equally well on adenosine,
guanosine, inosine, and uridine; these four molecules are
interchangeable from the point of view of the transport sys-
tem [12]. In order to avoid creating four almost identical reac-
tions for these nucleosides, Reactome's data model allows the
creation of two 'defined sets' for extracellular and cytosolic
nucleosides. SLC28A2-mediated nucleoside transport can
then be described as a single reaction that converts the extra-
cellular nucleoside set into the cytosolic set. Defined sets are
also used to describe protein paralogs that are functionally
interchangeable, equivalent RNA splice variants, and
isoenzymes.
Another type of set used by Reactome is the 'candidate set'.
This is used when the state of knowledge is incomplete and it
is believed that one out of several candidate physical entities
is responsible for a particular task. This is used, for instance,
to express the assertion that, 'The presence of a particular cyc-
lin-dependent kinase is responsible for this step in cell cycle
progression, but we do not know which one.'
Finally, there is an 'open set' class, which is used for cases in
which all members of the set cannot be explicitly enumerated.
For example, in the RNA transcription pathways, we need to
describe reactions that involve all mRNAs but we cannot enu-
merate all distinct mRNA molecules. Instead, we use an open
set named 'mRNA'. As we add distinct mRNA molecules to
the database, they become a part of this set, allowing them to
be treated simultaneously from the perspective of a generic
mRNA subject to transcriptional and splicing reactions, as
well as from the point of view of a distinct mRNA that is, for
example, under the control of a particular transcriptional
factor.Genome Biology 2007, 8:R39
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detailed and flexible annotation of physical entities and their
interactions. For example, Cdc2 protein (Universal Protein
Resource [UniProt]:P06493) can be phosphorylated in the
cytosol at threonine-14. The phosphorylated form of Cdc2 is
distinct from unmodified Cdc2. Both the phosphorylated and
unphosphorylated forms can also be found in complexes with
cyclins B1 or B2. Both of these cyclins are represented by a sin-
gle distinct entity, and the two of them together are repre-
sented collectively by a defined set called 'cyclin B'. The
complexes between the cyclins and Cdc2 are represented as
two instances of the complex class: one complex consisting of
the 'cyclin B' defined set and unphosphorylated Cdc2, and the
other consisting of the 'cyclin B' defined set and phosphor-
ylated Cdc2. These complexes then take part in the various
reactions of the cell cycle pathway. We can simultaneously
create complexes of Cdc2 with individual cyclins if a particu-
lar cyclin/Cdc2 complex does something that the others do
not.
The use of sets simplifies both the curation and the querying
of Reactome. For example, the web query interface allows
researchers to search for pathways involving 'cyclin B' and
obtain a comprehensive list. Without this functionality, a
researcher might have to search serially for each member of
the set of entities that together comprise cyclin B.
A critical aspect of the Reactome data model is evidence
tracking imposed at every level. Every reaction entered into
the knowledge base must be backed up by evidence from the
biomedical literature, and documented with appropriate cita-
tions. Reactome recognizes two types of evidence: direct and
indirect. Direct evidence for a reaction in humans comes from
a direct assay on human cells. However, much of current bio-
chemical knowledge has been developed from experiments
and observations in nonhuman species. Insights obtained in
one species are then projected onto other species on the basis
of sequence similarity of genes or proteins between the
respective species. When work in one species is used to make
inferences about a human pathway, it becomes Reactome
indirect evidence.
In practice, we use nonhuman experimental data to docu-
ment an inferred human biologic process with a two-step
process. First, we create a reaction that describes the reaction
in the nonhuman species, using physical entities that are
appropriate for the organism that was directly assayed, for
instance Drosophila Notch protein. The papers that describe
the experiments used to characterize the nonhuman reaction
become the direct evidence for that reaction in the knowledge
base. Next, we create an inferred reaction that describes the
reaction in human, using human physical entities, for exam-
ple the four human Notch paralogs. The nonhuman reaction
is now used as the evidence to support the inferred human
reaction. In this way, the complete chain of evidence is pre-
served from primary experiment to nonhuman reaction, to
the inferred human reaction.
Reactome uses well recognized external identifiers to estab-
lish connections with other public biologic databases. In addi-
tion to GO terms to describe molecular function, biologic
process and subcellular compartment, we use ChEBI (Chem-
ical Entities of Biological Interest [13]) and UniProt [14] to
reference small molecules and protein sequences, respec-
tively. These cross-references are mandatory fields in the cor-
responding Reactome records and are hand checked by
Reactome staff. In addition, we automatically cross-reference
proteins, genes, reactions, and other objects to a variety of
popular external databases, including Entrez Gene [15],
Online Mendelian Inheritance in Man (OMIM) [16], and
Kyoto Encyclopedia of Genes and Genomes (KEGG) [17]
(Table 1). We chose ChEBI and UniProt over other potential
reference datasets because these resources are heavily
curated to remove redundancy.
The data model includes several classes to describe special
cases such as biologic polymers and reactions that occur con-
currently within a pathway, as well as utility classes to aid in
Table 1
Database cross-references in Reactome
Database Protein Gene Small molecule Activity Compartment Process
UniProt Xa
Entrez Genes X
ChEBI Xa
GO Xa Xa Xa
Ensembl X
UCSC X
KEGG X X
OMIM X
aCurated cross-references. ChEBI, Chemical Entities of Biological Interest; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; 
OMIM, Online Mendelian Inheritance in Man; UCSC, UCSC Genome Browser; UniProt, Universal Protein Resource.Genome Biology 2007, 8:R39
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ncuration workflow management and the website user
interface. There are also classes in the data model that allow
us to describe functional submolecular domains in proteins,
nucleotide sequences, and other macromolecules.
Pathways and reactions can have attached summations
(human-readable text) and illustrations. Summations orient
the reader and summarize the process in textbook style. Sum-
mations can also be used to add comments that do not fit into
the Reactome data model.
Pathway authoring and curation
All of the information in Reactome comes from expert cura-
tion (Figure 1). Reactome curators, who are PhD-level biolo-
gists experienced with the data model and authoring tools,
together with the Reactome Scientific Advisory Board, iden-
tify specific biologic areas to be annotated for Reactome, as
well as areas already annotated that warrant revision to incor-
porate new data. Independent research scientists who are
recognized experts in these areas are then recruited to collab-
orate with Reactome as expert authors. Areas have the scope
of journal minireviews, with titles such as 'The TLR3 signal-
ing cascade' and 'Influenza virus packaging and release'. The
Reactome data model can accommodate alternative, contro-
versial versions of a single biologic process, as a matter of edi-
torial policy. However, in order to maximize the value of
Reactome as a data mining resource for users, experts are
asked to construct views of processes that reflect current
expert consensus.
Typically, the expert and a curator work together to create an
electronic outline to define the exact scope of the biologic
process to be annotated and to identify and order the reac-
tions that comprise the process. This initial process delimits
the biologic area to be annotated, identifying the module that
this expert will be authoring. The expert uses a graphical
application called the Reactome Author Tool (Figure 2) to add
molecular detail to the outline. This detail may include, for
example, the identities and subcellular locations of the mole-
cules that participate in each reaction, the role of each mole-
cule (input, output, regulator, or catalyst), the compositions
of multimolecular complexes, the order of reactions within a
pathway, citations of key primary research publications, and
brief free text descriptions of each reaction and pathway. The
curator then uses another graphical application called the
Reactome curator tool to revise this material and integrate it
into the Reactome data scheme. Molecules are linked to their
corresponding reference entities and, where appropriate,
organized into sets; catalyst activities are linked to GO molec-
ular function terms; and links are created between the new
reactions and ones already in Reactome. This information is
then uploaded directly from the curator tool into the Reac-
tome development database, so that it can be reviewed by the
expert author and other Reactome curators, viewing it on the
development version of the Reactome website. The curator
then revises the material as appropriate using the curator
tool.
Once the content of the module is approved by the author and
curation staff, it is peer-reviewed on the development web-
site, by one or more bench biologists selected by the curator
in consultation with the author. The peer review is open and
the reviewers are acknowledged in the database by name. Any
issues raised in the review are resolved, and the new module
is scheduled for release.
The Reactome release process
Reactome follows a quarterly release schedule. The process of
creating a release database begins with extracting the finished
modules and associated information into a separate 'slice'
database (Figure 1). Automated and manual quality assur-
ance procedures are run to check the completeness and con-
sistency of the data. If necessary, material in the development
database is revised and a new 'slice' database is generated.
Next, protein orthology mappings are used to computation-
ally predict reactions and pathways in other organisms (this
process is described in more detail in the following section).
We then add crosslinks to other relevant external resources.
After a final round of testing of data and web server testing,
the new database is made available via the public website
[18].
Reactome has had 19 releases since its first release in 2002.
The latest release (November 2006) contains 1,473 curated
human proteins, 1,845 reactions, and 691 pathways. This rep-
resents roughly 7% of the estimated 21,000 proteins in the
human genome [19], and 10% of the roughly 15,000 unique
accessions in the human division of UniProt. Reflecting the
Workflow for authoring and curation of new pathwaysFigure 1
Workflow for authoring and curation of new pathways. Red arrows 
indicate the part of the process involving interactions between curators 
and outside experts; black arrows indicate interactions between curators 
and software engineers. DB, database; RCDB, release candidate database.
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curation rate is roughly 15 new human proteins per curator-
month. Our goal, over the next 4 years, is to curate approxi-
mately 5,000 proteins manually, as described here, to acquire
information about another 5,000 through bulk importation
of data from other sources such as protein-protein interaction
databases, and thus provide a user at least even odds that a
query to Reactome about a human protein will return data.
Inference of pathways in other species
Since release 4, each Reactome release has included compu-
tationally inferred pathways and reactions in multiple nonhu-
man species, currently Mus musculus, Tetraodon
nigroviridis, Drosophila melanogaster, Caenorhabditis ele-
gans, Saccharomyces cerevisiae, Aspergillus nidulans, Ara-
bidopsis thaliana, Dictyostelium discoideum, Plasmodium
falciparum, Escherichia coli, Sulfolobus solfataricus, and 11
others. These species were selected because of the complete-
ness of their genome sequencing and annotation. Together
they represent more than 4,000 million years of evolution
and span the major branches of life.
The inference process begins with the set of peer-reviewed
curated human reactions in the pre-release database. We
project these curated reactions onto the genomes of the
selected species using protein similarity clusters derived by
the OrthoMCL method [20]. Briefly, this method begins with
an all-against-all BLASTP performed on all proteins from all
the species to be compared. OrthoMCL finds reciprocal best
similarity pairs of proteins for each protein and pair of spe-
cies, as well as 'reciprocal better' similarity pairs within spe-
cies. The latter are proteins that are more similar to each
other within the same species than to any protein in the other
species. These pairs are entered into a similarity matrix, nor-
malized by species, and then clustered using a Markov chain
length algorithm. The result is sets of related proteins that
include both orthologs and recent paralogs that postdate the
divergence of the two species.
The next step is the projection of human reactions onto the
other selected species. All curated reactions that involve at
least one accessioned protein are checked as to whether the
proteins involved in that reaction have at least one ortholog or
recent paralog (OP) in the other species. Both direct partici-
pants in the reaction and enzyme catalysts are considered. In
the case of protein complexes, we relax this requirement so
that a complex is considered to be present in the other species
if at least 75% of its protein components are present in the
other species as an OP. Reactions that meet these criteria are
considered 'qualified'.
For each qualifying reaction, we create an equivalent reaction
for the species under consideration by replacing all protein
components with their corresponding OP(s). For proteins
with more than one OP in the other species, we create a
defined set named 'Homologs of ...' containing the other spe-
cies' OPs, and use this defined set as the corresponding com-
ponent of the equivalent reaction.
In the case of complexes that match because of the 75%
threshold, some components will have OPs whereas others
will not. For those components that do not have an OP, we
create placeholder entries in the other species; that is, we
The Reactome author tool provides authors with a graphical user interface to describe pathways and their component reactions in a structured mannerFigur  2
The Reactome author tool provides authors with a graphical user interface to describe pathways and their component reactions in a structured manner.Genome Biology 2007, 8:R39
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ninfer that a complex exists in the other species that fulfills the
same role as the corresponding human complex, but it
includes unknown protein components (which might or
might not actually exist) as well as those defined by the OP
relationships.
Many reactions involve several proteins or complexes. In
order to match a putative reaction in another species, all
participants - including inputs, outputs, and catalysts - must
have a corresponding OP match in the other species.
To create inferred pathways, we connect the newly created
reactions in the same way that the original human reactions
were. In other words, we infer higher level reactions in the
other species as needed in order to replicate the topology of
the human pathway. This can cause problems when the pres-
ence of a single inferred reaction causes the creation of an
entire phantom pathway. For example, cytochrome c (Uni-
Prot P99999) is very well conserved across eukaryotes, and so
reaction in which this protein is released from mitochondria
during apoptotic cell death is inferred in all of these species
and causes creation of a pathway, 'apoptosis'. For this reason
we are considering implementing a more sophisticated future
criterion in which a minimum number of reactions is neces-
sary to create a pathway.
This method of electronically inferring nonhuman reactions
via orthology and recent paralogy information has important
limitations. Although we assume that a reaction occurs in
another species when all proteins involved in the human ver-
sion of the reaction have an OP in the species, this may not be
the case in reality because of diversification of the function of
the OP or changes in the tissue or developmental expression
pattern. On the other hand we may miss a true corresponding
reaction in the other species because the proteins involved
may have evolved at the amino acid level while maintaining
the same function. Parameters set for the clustering may not
fit all biologic ortholog groups.
In order to test the accuracy of our pathway inference proce-
dure, we sought to compare our predictions for an organism
evolutionarily distant from humans with the results of expert
manual curation in that organism. We took advantage of
Yeast Biochemical Pathways (YBP), a set of intermediary
metabolism pathways from S. cerevisiae independently
curated by experts at the Saccharomyces Genome Database
(SGD) [21]. These pathways were originally generated using
the PathoLogic software, part of the Pathway Tools package
[22], from the multispecies pathways database MetaCyc [23].
The focus of YBP is intermediary metabolism, whereas Reac-
tome covers both intermediary metabolism and reactions
that involve proteins, large carbohydrates and nucleic acids.
To create comparable datasets, we randomly selected 71
curated human reactions from the intermediary metabolism
section of Reactome release 17. After removing three equiva-
lent reactions in which the same chemical reaction is cata-
lyzed by paralogous isoenzymes, we were left with 68
reactions in the test set.
We next hand-matched the 68 human reactions to curated
reactions in YBP using the YBP web-based query interface. In
order to be called a match, the reactants and products of the
reactions had to be identical, and the catalysts had to be
orthologous to each other by OrthoMCL criteria. Under these
criteria, we found that 28 human reactions matched YBP
reactions and 31 did not. These 31 reactions included several
plasma membrane transport reactions and components of
pathways that are highly diverged between fungi and verte-
brates. An additional nine YBP entries matched at the reac-
tant level, but the YBP record failed to identify the yeast
protein responsible for the reaction's enzymatic activity. This
left us with 59 reactions that had a definite YBP match or
match absence.
We next ran the standard reaction inference algorithm
against the matched and unmatched reactions to yield a total
of 27 inferred yeast reactions. Of the 28 hand-matched reac-
tions, the inference algorithm correctly identified 20 reac-
tions and missed four, for a false-negative rate of 28%. The
balance of four inferred algorithms correctly inferred the sub-
strates of curated yeast reactions, but they did so by matching
the wrong catalyst - often an ortholog whose substrate specif-
icity is known to have changed over the course of evolution.
We scored these as false positives. Of the 31 human reactions
that did not have an apparent yeast equivalent, the inference
algorithms predicted three yeast reactions, which, when com-
bined with the four incorrect catalyst assignments, give a
false-positive rate of 22%.
Of the nine human reactions that were hand-matched to
incomplete YBP records, the inference algorithm predicted
corresponding yeast reactions in five cases, and failed to infer
a reaction in four. Because the YBP record was missing infor-
mation on the catalytic protein, however, we do not know
whether these inferences were correct.
From this exercise we estimate that the sensitivity of the
inference algorithm is 72% (95% confidence interval ± 15%).
The specificity of the inference procedure is 78% (95% confi-
dence interval ± 15%).
We examined the false negatives in more detail. One false
negative was the following reaction: 2 glutathione, reduced +
H2O2  glutathione, oxidized + 2 H2O. This reaction is cata-
lyzed by human GPX1, and by the proteins encoded by yeast
genes YKL026C (GPX1), YBR244W (GPX2), and YIR037W
(GPX3). These three yeast proteins share similarity to human
GPX4 and GPX7, but they are not homologous to GPX1.
Therefore, this seems to be a case in which the reaction is con-
served across the two species, but a different gene encodes the
enzyme that catalyzes it.Genome Biology 2007, 8:R39
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anthine + 5-phospho-α-D-ribose 1-diphosphate  inosine
monophosphate + pyrophosphate. This is catalyzed by
hypoxanthine phosphoribosyltransferase (HPRT1) in human
and its homolog HPT1 in yeast. These proteins are homolo-
gous at the amino acid level, although weakly so, but they are
not co-clustered by OrthoMCL. This example would appear to
represent a limitation in the OrthoMCL clustering algorithm.
The false positives were also interesting. In four cases, the
human reaction does occur in yeast, but it is catalyzed by an
enzyme that is different from the one predicted by the infer-
ence algorithm. For example, the following reaction occurs in
both human and yeast: lysine + α-ketoglutarate + NADPH +
H+ → saccharopine + NADP+ + H2O. YBP indicates that this
enzyme is catalyzed by yeast protein LYS1 (YIR034C),
whereas the Reactome inference predicted the yeast reaction
to be catalyzed by LYS9 (YNR050C). However, YBP annotates
this latter protein as catalyzing the following reaction: gluta-
mate + L-2-aminoadipate 6-semialdehyde + NADPH + H+ →
saccharopine + NADP+ + H2O. This is an apparent case of a
change in substrate specificity. Another false positive
involved the projection of the following reaction: guanidinoa-
cetate + S-adenosylmethionine → creatine + S-adenosylho-
mocysteine. This reaction is not documented by YBP to occur
in yeast, but the Reactome inference procedure projected it
onto yeast using a homologous enzyme that is annotated as
being an arginine methyltransferase that acts on yeast ribos-
omal protein L12. Finally, in one case, Reactome inferred the
following reaction to yeast: 4a-hydroxytetrahydrobiopterin
→ q-dihydrobiopterin + H2O. To do this it used a yeast pro-
tein annotated as an open reading frame of unknown function
(YHL018W). Although it is possible that we have correctly
predicted the function of an uncharacterized yeast protein, we
consider this unlikely because we were unable to find any lit-
erature-based evidence that S. cerevisiae metabolizes q-dihy-
drobiopterin or related molecules.
The list of reactions used in this exercise and their matching
YBP entries is available in Additional data file 1.
Practical applications of Reactome
The Reactome website [18] can be browsed like an online
textbook. The website's front page, shown in Figure 3, fea-
tures a large 'reaction map' that summarizes all of the cur-
rently curated or inferred pathways, and a table of contents
that describes each of the top-level pathways in the database.
In the reaction map, each reaction is represented as a small
arrow, and arrows are joined end to end to indicate that the
output of one reaction becomes the input of the next. The
reactions are organized in distinctive patterns to allow
researchers to become familiar with the different parts of the
reaction network. For example, the tricarboxylic acid (TCA)
cycle (Figure 3, arrow) is drawn as a circle. As the user moves
the mouse over the table of contents, the corresponding reac-
tions in the reaction map are highlighted. Conversely, if the
user moves the mouse over the reaction map, the correspond-
ing pathway name is highlighted in the table of contents.
By default, human data are displayed for each top level path-
way listed in the table of contents. However, choosing an
alternative species from the dropdown menu above the reac-
tion map will take the researcher to the list of pathways that
have been inferred in that organism.
The researcher can drill down into the database by clicking on
a reaction in the reaction map or by clicking on any of the top-
level pathways in the table of contents. Pathways are organ-
ized in a hierarchy, so that as researchers drill down pathways
are described with increasing detail. For example, a
researcher who clicks on 'apoptosis' is taken first to a general
review of the topic, and shown subtopics for the apoptosis
extrinsic pathway, the apoptosis intrinsic pathway, Bid pro-
tein activation, and the apoptotic execution phase. Eventu-
ally, researchers can drill down to individual reaction pages,
such as the one shown in Figure 4, which display the
individual components (inputs, outputs, and catalytic activi-
ties) of a reaction.
At each level of description, researchers can view the direct or
indirect evidence for the pathway or reaction. At the pathway
level the evidence is usually a review article that describes the
pathway in general terms. At the reaction level, the evidence
is one or more citations from the primary literature that con-
firm the reaction's existence.
From a pathway or reaction page, researchers can download
lists of accession numbers for all involved genes and proteins.
They can also download a summary of the pathway or reac-
tion in .pdf (human readable), Systems Biology Markup Lan-
guage (SBML) [24], or Biological Pathways Exchange
(BioPAX) level 2 [25] format for computational analysis.
SBML is an exchange format commonly used for kinetic mod-
eling of biologic systems, whereas BioPAX is an exchange for-
mat designed to describe complex biologic systems.
Pathway and reaction pages are linked to genome databases
at UniProt, Entrez Gene, OMIM, and elsewhere (Table 1). A
button allows researchers to view the current pathway in the
Cytoscape network browser tool [26].
Reactome provides users with the ability to search the data-
base using the name of a reaction, a gene name, a protein
name, or any of several other identifiers. For example, to find
all reactions involving the human TRAF1 protein, researchers
can simply type 'TRAF1' into the search box located at the top
of every page. However, more specialized queries are availa-
ble as well. The most powerful facility is called the 'Sky-
Painter' - a utility that allows researchers to visualize their
own datasets on top of the reaction map. To use the Sky-
Painter, researchers cut and paste a list of gene identifiersGenome Biology 2007, 8:R39
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ninto a web form, or upload a file of identifiers using an upload
button. After submitting the form, the SkyPainter uses statis-
tical analysis based on the hypergeometric test [27] to color
pathways according to the statistical likelihood that they
would contain the listed genes by chance. This highlights
those pathways in which the uploaded genes are over-repre-
sented.
The SkyPainter recognizes a large number of gene identifiers,
including EntrezGene names, accession numbers, and
Affymetrix probe sets. It also accepts numeric values, such as
expression levels from a microarray experiment. For exam-
ple, a researcher who is using a microarray to compare a can-
cerous tissue with a normal control can upload the intensity
values from the two experiments to SkyPainter, and it will
color the reaction map with red and green to indicate reac-
tions involving genes whose expression is increased or
decreased in the malignant cells relative to the normal con-
trols. The SkyPainter can render more complex data, such as
a time course series, as an animated movie.
The ortholog-based reaction inference procedure described
earlier provides a rough view of how biologic pathways evolve
with time. In Reactome release 18, there were 1,784 curated
human reactions and 1,450 curated proteins. We projected
these onto 12,649 reactions and 17,530 proteins in 22 nonhu-
man species (Table 2). The probability of successfully infer-
ring a reaction is greatest with closely related species, such as
rat, and least with distantly related species, such as Methano-
coccus spp.
The probability of success also varies considerably from path-
way to pathway. Figure 5 uses the SkyPainter tool to color the
reaction map to represent the most distant species in which
we were able to make an inference. Certain pathways, such as
polymerase II transcription of mRNA, are highly conserved
even among such distant species as the parasitic protozoan
Plasmodium falciparum. Others, such as the Notch signaling
pathway, can only be inferred among metazoans.
One observation that arises from this visualization is that
most pathways do not change in a piecemeal manner.
Instead, sets of reactions are coordinately gained and lost in a
modular way; if one component of a reaction module is
absent from a species, then the chances are high that all reac-
tions in the same module will be absent.
Another intriguing observation is a recurrent pattern in
which the reactions in the inner core of some pathways are
more likely to be conserved across large evolutionary dis-
tances, whereas those reactions present at the edges of the
same pathways tend to be found only in species closely related
The Reactome home pageFigur  3
The Reactome home page. The bold arrow in the reaction map at top points to the tricarboxylic acid (TCA) cycle.Genome Biology 2007, 8:R39
R39.10 Genome Biology 2007,     Volume 8, Issue 3, Article R39       Vastrik et al. http://genomebiology.com/2007/8/3/R39to human. This pattern is particularly noticeable in DNA
repair, translation, carbohydrate metabolism, and nucleotide
metabolism. This observation suggests at least two possible
mechanisms. One, as first proposed by Horowitz [28] more
than 60 years ago, is that biologic pathways evolve from their
centers toward their peripheries. A heterotrophic organism
that requires substance A as the input into an essential meta-
bolic pathway will have a selective advantage if it develops the
ability to metabolize substances B and C, also present in the
environment, into substance A. Hence, as evolution proceeds,
core pathways develop novel branches that enable them to
use additonal substrates. A second potential explanation for
this observation is that the cores of biologic pathways are
more constrained than their edges, for example because of
increased numbers of regulatory interactions, so that they are
exposed to greater degrees of purifying selection than reac-
tions at the periphery. We may be seeing the effects of one or
both of these mechanisms.
Because Reactome is heavily curated, we believe it to have a
low rate of false reactions. This makes it a good 'gold stand-
ard' for training machine learning systems that attempt to
infer the presence of genetic or physical interactions from
high-throughput datasets. Indeed, Reactome has been used
in this way by two independent groups. Ramani and cowork-
ers [29] benchmarked Reactome against several other
curated datasets (Human Protein Reference Database, BIND,
KEGG, and GO) before selecting training sets for a Bayesian
classifier for bimolecular protein interactions. Measured
against interactions mined from co-occurrence of gene names
in the literature, Reactome had the highest accuracy and was
ultimately chosen to train the network. More recently, Franke
and coworkers [30] used Reactome as the training set for an
application that prioritizes genetic association study gene
candidate lists. This system, which also uses a Bayesian
framework, identifies common pathways among sets of genes
identified by genetic association to a trait of interest.
Discussion
The concept of a pathway database is, of course, not a novel
one. One of the earliest publicly accessible pathway databases
dates back to 1992, with the development of EcoCyc [31,32],
an online database of the Escherichia coli genome and its
metabolic pathways. EcoCyc has been followed by a series of
metabolic pathway databases based on the EcoCyc infrastruc-
ture, including HumanCyc, a database of human pathways
[33,34].
Although HumanCyc includes a modest number of curated
reactions, much of it is created computationally from
sequence similarity on top of an EcoCyc template. Hence, the
A reaction pageFigure 4
A reaction page.Genome Biology 2007, 8:R39
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ncontent of HumanCyc is very much geared toward metabo-
lism. HumanCyc's data model is similar in many respects to
Reactome's, and it is built on top of the concept of a reaction
that transforms a set of inputs into a set of outputs. The Reac-
tome SkyPainter tool and the HumanCyc Omics Viewer [22]
are also similar in design and functionality, aside from the
latter's emphasis on metabolic pathways. However, Human-
Cyc goes beyond Reactome in curating other information
about the components of its reactions; for example, it tracks
information about the exon structure of genes and their map
positions, as well as the chemical structures of small mole-
cules. Reactome, in contrast, links to this information in the
appropriate public databases. HumanCyc uses PathoLogic
[22] to infer pathways from one species to another. This soft-
ware implements a Bayesian algorithm that takes pathway
topology information into account. Reactome, in contrast,
uses a less sophisticated approach that takes the human path-
way topology as given and matches individual reactions. As
noted above, the Reactome method has the drawback that it
can create 'phantom' pathways that contain a single inferred
reaction. Unfortunately, in our assessment of Reactome's
inference procedures, we were unable to compare our infer-
ence algorithm against HumanCyc's because of the fact that
PathoLogic inferences were used as the starting material for
SGD's pathway curation.
Another popular pathway database is the pathways division
of KEGG [17,35], which contains curated metabolic and sign-
aling pathways in species ranging from prokaryotes to
humans. KEGG has several important limitations. One is that
it uses different data models to represent metabolic and sign-
aling pathways. Although metabolic pathways are repre-
sented as chemical reactions, signaling pathways are
represented as semantic graphs in which the nodes (mole-
cules or complexes) exert positive or negative influence on
other nodes. Signaling pathways thus cannot be connected
computationally to metabolic pathways. Another limitation
of KEGG is its reliance on Enzyme Commission (EC) numbers
to associate metabolic reactions with the physical polypep-
tides contained in protein and gene databases. This leads to
ambiguous, and sometimes incorrect, assignments.
Panther Pathways [36,37] is a curated collection of human
pathways with an emphasis on signaling. Panther's data
model is based on the Cell Designer application [38,39],
which, like Reactome, represents pathways as chemical reac-
tions. Proteins participating in reactions are represented not
by single molecules but by sets of proteins, assembled as hid-
den Markov models. For example, '5HT (5-hydroxytryp-
tamine) transporter' is a set of two human, four mouse, two
rat, and two bovine proteins [40]. A second substantive dif-
Table 2
Inferred reactions in target species
Species Proteins Complexes Reactions Pathways
H. sapiens 1450 1,329 1,784 689
E. histolytica 570 139 228 193
D. discoideum 714 499 598 347
P. falciparum 328 235 283 215
C. merolae 507 371 470 292
S. pombe 619 411 509 321
S. cerevisiae 633 401 510 313
N. crassa 571 448 601 349
C. neoformans 481 334 460 292
C. elegans 889 513 693 394
G. gallus 1,600 739 1,023 492
M. musculus 1,670 1,075 1,376 559
R. norvegicus 1,907 981 1,267 547
T. nigroviridis 1,358 880 1,135 499
D. melanogaster 1,461 646 841 446
T. pseudonana 587 377 536 327
A. thaliana 1,361 494 596 356
O. sativa 1,645 453 562 335
Synechococcus spp. 75 60 154 115
E. coli 167 131 263 162
M. tuberculosis 159 150 273 167
M. jannaschii 64 47 112 105
Total nonhuman 17,530 9,473 12,649 6,964Genome Biology 2007, 8:R39
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resources is the curation model; Panther Pathways empha-
sizes rapid but shallow curation by nonexperts, primarily
part-time graduate students and postdoctoral fellows, sup-
plemented by a small number of more senior researchers.
Other human pathway resources include BioCarta project
[41], a database of pathway cartoons; GenMAPP [42], a path-
way visualization tool; the interaction databases BIND [9],
Molecular INTeraction (MINT) [43], and IntAct [44]; the
protein databases UniProt [14] and HPRD [45]; descriptive
resources such as the Science Signal Transduction Knowledge
Environment [46] and the Alliance for Cell Signaling web site
[47]; and proprietary products such as the Ingenuity Path-
ways Knowledge Base [48]. Although these resources often
contain extensive data and analysis tools, none of them pro-
vides both a publicly accessible internal structure and a data
model that allows the full range of human biologic pathways
to be represented as computable chemical reactions.
Reactome is distinguished by its uniform treatment of all bio-
logic pathways. It uses the same data model to describe
metabolism, signal transduction, DNA replication, the regu-
lation of the cell cycle, and all other biologic processes. This
allows Reactome to make connections among these proc-
esses. For example, although every pathway database pro-
vides the same, correct view of the metabolic steps leading
from glucose 6-phosphate to pyruvate, at present only
Reactome is able to capture the positive allosteric regulation
of the committed step of the pathway, namely conversion of
fructose 6-phosphate to fructose 1,6-bisphosphate by fructose
2,6-bisphosphate, and the signaling cascades that link syn-
thesis of the latter compound to levels of the hormones gluca-
gon and insulin. Eliminating artificial distinctions between
metabolism, regulatory pathways and higher order reactions
makes it possible to write software that computes over the
whole biologic reaction network and not arbitrary subdivi-
sions of it.
The known biologic pathways are only a tiny fraction of what
goes on in the cell. The next decade will see an ever-expanding
flood of biologic information that is likely to overwhelm even
the largest curatorial groups. We feel that the way forward is
to decentralize and distribute the task of describing pathways
in computable and searchable form. To further this vision, we
have made Reactome into an open source project. The Reac-
tome data and software are freely available to all users and
can be downloaded from the Reactome website [49]. We
strongly encourage interested groups to download the Reac-
tome database and software, install it locally, set up their own
large or small-scale curatorial effort, and contribute curated
pathways back to the main Reactome website for use by the
community. In a like manner, we are working with the devel-
opers of GenMAPP and other pathway software developers to
incorporate support into their applications so that pathways
created with these tools can be stored into and retrieved from
Reactome databases.
Finally, we encourage other pathway database groups to fully
support BioPAX, SBML, and other emerging standards for
pathway data exchange, as well as to make use of commonly
recognized controlled vocabularies for proteins and small
molecules. This will promote the sharing of biologic pathway
data among the databases and will speed us toward the ulti-
mate goal of putting all biologic pathway information into a
computable form.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 tabulates the
results of matching 68 randomly chosen metabolic reactions
manually curated in human to the corresponding S. cerevi-
siae reactions inferred using the OrthoMCL-based procedure
and corresponding manually curated entries in SGD YBP.
Additional data file 1Results of m ch ng 68 randomly chosen metabolic reactions man-ually cur te  in uman to the corresponding S. cerevisiae reactions inferred using t e OrthoMCL-bas d procedure and corr spondi gmanually curated ntries in SGD YBPTh  file t b l s the esults of matchi g 68 r ndomly chose  etabol  re tions ma ually curated in human to th  corresponding S. ce visiae reac ions inferred using the Or hoMCL-b sed proc -dur  (see R sult ) d c rresp nd g ma ually curated entries ithe SGD YBP.Cli k h re fo  file
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